Allergy and Immunization CME

Stay on top of your game with the StatPearls Physician Unlimited CME programs. With 6,046 activities, StatPearls is the largest CME provider in the world. These Pub-Med Indexed articles are categorized into 162 specialty areas which lets you better access activities that will make the biggest impact on your practice. One subscription allows access to all the activities, including all state-requirements.

Pricing Options

• 6 Month subscription: All 6,339 CME Activities – $249 per 6 months
• Annual subscription: All 6,339 CME Activities – $349 per 1 year
• Lifetime: All 6,339 CME Activities + Access to Board Reviews Forever – $1999

Activity Description / Statement of Need:
In this online, self-learning activity:

Systemic mastocytosis (SM) is a heterogeneous group of disorders caused by proliferation of abnormal clonal mastocytes, which accumulate in the skin and/or other organ systems. Mastocytosis, including SM, was reclassified as a distinct disease subtype in 2016, when the World Health Organization (WHO) removed mastocytosis from the myeloproliferative neoplasm (MPN) group. The WHO defines 5 SM subtypes, ranging from indolent SM, which is associated with mild symptoms and near-normal life expectancy, to mast cell leukemia, which is an aggressive hematologic malignancy associated with median survival of less than 1 year.

Target Audience:
HCPs including: hematology/oncology specialists, allergists, and clinical immunologists, dermatologists; physician assistants, nurse practitioners, and pharmacists who practice in those areas of specialty; and any other healthcare professionals with an interest in or who may clinically encounter patients with systemic mastocytosis.

Physicians specializing in Allergy or Dermatology.

Target Audience:
Physicians specializing in Immunology, Nephrology, Urology

Some popular articles and quizzes include:
• Gene-environment interactions in asthma and allergic diseases
• Allergy to B-lactam antibiotics
• Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species
• Cutaneous drug reactions
• IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies
• Evaluation and management of a patient with chronic pruritus
• Human versus mouse eosinophils

Target Audience: Physicians focusing on Allergy, Chest Medicine

CME activities of special interest to allergists and immunologists. Medscape contains a variety of educational formats:

CONFERENCE COVERAGE – Reports of advances presented at major medical conferences; typically includes several tracks with news stories, expert interviews, and in-depth topic overviews.

CLINICAL UPDATE – Comprehensive original review article on scientific advances in a clinical topic.

FAST TRACK CLINICAL UPDATE – Narrowly focused original review article on scientific advances in a clinical topic.

CME-LIVE – Real-time online events with streaming video, synchronized visuals, and interactive questions and answers; archived for 1 year.
CLINICAL BRIEFS – Daily reports of major current medical research articles; 0.25 credits each

JOURNAL CME – Articles selected from a wide selection of peer-reviewed journals.
SPECIAL REPORT CME – Topic-based monthly email newsletter distributed to Medscape’s professional member database by specialty.

INTERACTIVE PATIENT CASES – Original CME activity presented to the physician in an interactive, clinical case-based format. (See especially eMedicine CME Case Presentations.)

CME CIRCLE – Multimedia content certified by other accredited professional education providers, typically from live symposia or monographs, and then posted on Medscape and archived for one year.

Target Audience: ALLG

Target Audience: Physicians focusing on Allergy or Dermatology

This Pediatrics and Allergy CME course contains 3 activities and offers 0.75 AMA PRA Category 1 Credits™.

After completing this course, you will better be able to:

• Assess the burden of food allergy in children.
• Evaluate appropriate tools and strategies for the diagnosis and management of children with IgE-mediated food allergy.
• Examine the comparative benefits and limitations of available and emerging methods for immunotherapy for the treatment of food allergy in children.
• Explain the clinical and practical significance of increasing the allergen response threshold via immunotherapy.

Primary immunodeficiency disorders (PIDD) comprise a group of 430 different known inborn errors of immunity. The heterogeneous etiology of PIDD leads to a vast array of clinical presentations, including infection, malignancy, autoimmunity, and inflammation. Once thought to be exceedingly rare, PIDD is increasingly being recognized as an underdiagnosed disease affecting between one in 1,000 to one in 5,000 births.

Because a significant percentage of people with PIDD are undiagnosed, improving the recognition of PIDD signs and symptoms necessarily forms the foundation of PIDD-focused medical education efforts. Early treatment improves outcomes and health-related quality of life in children and adults with PIDD, yet time from symptom onset to diagnosis can exceed 4 years. Diagnostic lag has serious consequences for many patients with PIDD due to recurrent infections, which may take a toll on pulmonary function. In a large-scale analysis of patients with common variable immunodeficiency, a common form of PIDD, risk of death increased by 1.7% each year of diagnostic delay.  The most up-to-date guidance around the classification of PIDD and how to determine related genetic tests has been published relatively recently. Communicating related information to HCPs in a timely manner is a demonstrated need.